Ritu Singh

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Periconceptional GLP-1 Receptor Agonist Exposure
  JACC: Advances 2026 DOI: 10.1016/j.jacadv.2026.103152
  +Save
• Short‐Term HbA1c Non‐Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability
  Diabetes, Obesity and Metabolism 2026 DOI: 10.1111/dom.71097
  +Save
• Synthetic Versus Reference Semaglutide for Weight Management: Reporting Gaps and Clinical Claims
  Diabetes, Obesity and Metabolism 2026 DOI: 10.1111/dom.71283
  +Save
• Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis”
  Journal of Lipid and Atherosclerosis 2022 DOI: 10.12997/jla.2022.11.1.84
  +Save
• Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes
  International Journal of General Medicine 2021 DOI: 10.2147/IJGM.S295459
  +Save
• Do SGLT‐2 inhibitors exhibit similar cardiovascular benefit in patients with heart failure with reduced or preserved ejection fraction?
  Journal of Diabetes 2021 DOI: 10.1111/1753-0407.13182
  +Save